Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Full Enrollment	STARTED	Active Group	81
Full Enrollment	STARTED	Placebo Group	39
Full Enrollment	COMPLETED	Active Group	81
Full Enrollment	COMPLETED	Placebo Group	39
Full Enrollment	NOT COMPLETED	Active Group	0
Full Enrollment	NOT COMPLETED	Placebo Group	0
Full Analysis Set (FAS)	STARTED	Active Group	81
Full Analysis Set (FAS)	STARTED	Placebo Group	39
Full Analysis Set (FAS)	COMPLETED	Active Group	77
Full Analysis Set (FAS)	COMPLETED	Placebo Group	38
Full Analysis Set (FAS)	NOT COMPLETED	Active Group	4
Full Analysis Set (FAS)	NOT COMPLETED	Placebo Group	1
Safety Analysis Population	STARTED	Active Group	81
Safety Analysis Population	STARTED	Placebo Group	39
Safety Analysis Population	COMPLETED	Active Group	77
Safety Analysis Population	COMPLETED	Placebo Group	38
Safety Analysis Population	NOT COMPLETED	Active Group	4
Safety Analysis Population	NOT COMPLETED	Placebo Group	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04334460/flow